ExodusPoint Capital Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,612
Closed -$355K 1501
2025
Q2
$355K Sell
3,612
-28,807
-89% -$2.73M ﹤0.01% 1219
2025
Q1
$3M Buy
32,419
+28,496
+726% +$2.63M 0.03% 561
2024
Q4
$356K Buy
+3,923
New +$360K ﹤0.01% 1234
2023
Q4
Sell
-3,078
Closed -$287K 1428
2023
Q3
$287K Sell
3,078
-556
-15% -$51.4K ﹤0.01% 1430
2023
Q2
$332K Sell
3,634
-43,620
-92% -$3.58M ﹤0.01% 1498
2023
Q1
$3.48M Buy
47,254
+17,571
+59% +$1.52M 0.03% 653
2022
Q4
$2.48M Buy
+29,683
New +$2.68M 0.04% 564
2021
Q4
Sell
-2,841
Closed -$424K 2131
2021
Q3
$424K Sell
2,841
-7,605
-73% -$1.58M 0.01% 1482
2021
Q2
$2.56M Buy
10,446
+8,485
+433% +$2.23M 0.03% 573
2021
Q1
$519K Buy
+1,961
New +$553K 0.01% 1315
2020
Q4
Sell
-1,292
Closed -$305K 1925
2020
Q3
$305K Sell
1,292
-31,436
-96% -$7.15M 0.01% 1270
2020
Q2
$6.5M Buy
+32,728
New +$6.1M 0.17% 113

Other funds holding AMED

ExodusPoint Capital Management's AMED Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,612 shares — an estimated $355K sold.

ExodusPoint Capital Management first reported a position in AMED in Q2 2020 and held it in 12 quarters. The position peaked at $6.5M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • ExodusPoint Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 3,612 Amedisys shares in Q3 2025, an estimated $355K.
  • ExodusPoint Capital Management first reported a position in Amedisys in Q2 2020 and held it in 12 quarters.
  • ExodusPoint Capital Management's Amedisys position peaked at $6.5M in Q2 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.